drugset / Trial / NCT00361452

Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study

NCT00361452

Phase 4 Terminated 30 enrolled Rambam Health Care Campus
RandomizedParallel-groupDouble-blindTreatment

Summary

Bronchiolitis is a common disease of infancy and a main reason for infants' hospital admissions in the first 2 years of life. The main cause of bronchiolitis is RSV (respiratory syncytial virus). Though, Treatment is mainly supportive, the treatment benefit of nebulized epinephrine or albuterol has been largely debated for the past years. Most of the clinical studies used clinical parameters to detect and compare the effectiveness of such medical interventions. In this study we will use non invasive computerized method of wheeze and crackles quantification to compare the effectiveness of nebulized epinephrine vs albuterol in RSV Bronchiolitis.

Timeline

Start
2000-12
Primary completion
Completion
2001-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 1 mg Other
Subject Salbutamol Unknown 2.5 mg Other